Moreover, Song et al. showed that the application of a BM-MSC therapy in a mice model of adriamycin-induced nephropathy significantly decreased the levels of pro-inflammatory cytokines as INF-γ, TNF-α and IL-12, and ROS (Song et al., 2018). Here, TNF is linked to kidney disorder.